what is the dark side of semaglutide multifaceted effects semaglutide: exploring its broad therapeutic applications How to Manage (or Prevent)

In the intervention arm, weight loss was greater in the first year than at the end of follow-up (8.6% versus 0.7% in controls at 1 year

General practice management of type 2 diabetes: 201618

Here are the mistakes worth catching before you draw

Educate patients taking GLP-1 receptor agonists who have risk factors for developing NAION about the importance of presenting to their eyecare provider immediately should they experience any painless monocular vision loss

Study size Based on data from a pilot study, the required sample size was calculated to be 30 participants to achieve 80% power at a two-sided significance level () of 0.05

doi: 10.2174/0118715206342278241008081126 206 ZhaoHAoLSorinaWeiYYinHZZhangNet al